Endometriosis and adenomyosis: shared pathophysiology.
Bulun SE, Yildiz S, Adli M, Chakravarti D, Parker JB, Milad M, Yang L, Chaudhari A, Tsai S, Wei JJ, Yin P.
Fertil Steril. 2023 May;119(5):746-750. doi: 10.1016/j.fertnstert.2023.03.006. Epub 2023 Mar 15.
Progesterone Actions and Resistance in Gynecological Disorders.
MacLean JA 2nd, Hayashi K.
Cells. 2022 Feb 13;11(4):647. doi: 10.3390/cells11040647.
Adenomyosis pathogenesis: insights from next-generation sequencing.
Bulun SE, Yildiz S, Adli M, Wei JJ.
Hum Reprod Update. 2021 Oct 18;27(6):1086-1097. doi: 10.1093/humupd/dmab017.
Medroxyprogesterone.
Sathe A, Patel P, Gerriets V.
2024 Feb 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Abnormal uterine action.
WHAPHAM EM.
Nurs Mirror Midwives J. 1946 Jul 6;83:241.
Postpartum Hemorrhage.
Newsome J, Martin JG, Bercu Z, Shah J, Shekhani H, Peters G.
Tech Vasc Interv Radiol. 2017 Dec;20(4):266-273. doi: 10.1053/j.tvir.2017.10.007. Epub 2017 Oct 10.
Abnormal uterine action in labour.
BELL GH, NIXON WC.
J Obstet Gynaecol Br Emp. 1952 Oct;59(5):617-62. doi: 10.1111/j.1471-0528.1952.tb14737.x.
Uterine action, normal and abnormal.
NIXON WC.
Am J Obstet Gynecol. 1951 Nov;62(5):964-84. doi: 10.1016/0002-9378(51)91017-4.
The function and mechanism of action of uterine microecology in pregnancy immunity and its complications.
Shen L, Wang W, Hou W, Jiang C, Yuan Y, Hu L, Shang A.
Front Cell Infect Microbiol. 2023 Jan 4;12:1025714. doi: 10.3389/fcimb.2022.1025714. eCollection 2022.
Long-acting reversible contraceptives effects in abnormal uterine bleeding, a review of the physiology and management.
Castillo K, Zambrano K, Barba D, Robayo P, Sanon S, Caicedo A, Jijon Chiriboga AJ.
Eur J Obstet Gynecol Reprod Biol. 2022 Mar;270:231-238. doi: 10.1016/j.ejogrb.2022.01.020. Epub 2022 Jan 31.
